Cytori's Licensee Lorem Gets Regulatory Clearance In China For Cytori Celution

(RTTNews) - Cell Therapy company Cytori Therapeutics, Inc. (CYTX) Monday said its exclusive licensee, Lorem Vascular Pte. Ltd, has been granted regulatory clearance for the Cytori Celution System by the State Food and Drug Administration of the People's Republic of China or CFDA.

Cytori said Singapore based Lorem Vascular will begin product launch of Celution in key hospitals in China immediately.

Cytori Cell Therapy is under evaluation in the United States for treatment of patients with hand and finger involvement due to the autoimmune condition scleroderma, and symptomatic knee osteoarthritis.